|
Volumn 22, Issue 3, 1995, Pages 283-296
|
Fluorinated benzamide neuroleptics-III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE;
BENZAMIDE DERIVATIVE;
DOPAMINE RECEPTOR;
DOPAMINE RECEPTOR BLOCKING AGENT;
EPIDEPRIDE;
FALLYPRIDE;
FLUORINE 18;
HALOPERIDOL;
NEUROLEPTIC AGENT;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
BRAIN;
CONTROLLED STUDY;
DRUG SYNTHESIS;
INTRAVENOUS DRUG ADMINISTRATION;
ISOTOPE LABELING;
MONKEY;
POSITRON EMISSION TOMOGRAPHY;
ANIMAL;
ANTIPSYCHOTIC AGENTS;
BENZAMIDES;
BINDING, COMPETITIVE;
BRAIN;
CEBUS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
FLUORINE RADIOISOTOPES;
MACACA MULATTA;
MALE;
MOLECULAR STRUCTURE;
PYRROLIDINES;
RADIOACTIVE TRACERS;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, DOPAMINE D2;
STRUCTURE-ACTIVITY RELATIONSHIP;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, NON-P.H.S.;
TISSUE DISTRIBUTION;
TOMOGRAPHY, EMISSION-COMPUTED;
|
EID: 0028964653
PISSN: 09698051
EISSN: None
Source Type: Journal
DOI: 10.1016/0969-8051(94)00117-3 Document Type: Article |
Times cited : (194)
|
References (37)
|